(Q39405635)

11 September 2017

title

Spinal morphine in nonmalignant chronic pain: a retrospective study in 39 patients (English)

1 reference

11 September 2017

0 references

1 reference

Maria Luisa Franco Gay

series ordinal

1

1 reference

11 September 2017

publication date

1 July 2002

1 reference

11 September 2017

1 reference

11 September 2017

volume

5

1 reference

11 September 2017

issue

3

1 reference

11 September 2017

page(s)

150-159

1 reference

Intraspinal morphine for chronic pain: a retrospective, multicenter study

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Long-term intraspinal infusions of opioids in the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Intrathecal granuloma after implantation of a morphine pump: case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Spinal cord compression by catheter granulomas in high-dose intrathecal morphine therapy: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Drug adverse events and system complications of intrathecal opioid delivery for pain: origins, detection, manifestations, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide in serum and cerebrospinal fluid following morphine administration to patients with morphine-resistant pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Morphine-6-glucuronide disposition in renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

The metabolism and bioavailability of morphine in patients with severe liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

The pharmacokinetics of morphine and morphine glucuronides in kidney failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Clinical realities and economic considerations: special therapeutic issues in intrathecal therapy--tolerance and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Clinical realities and economic considerations: economics of intrathecal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Intrathecal morphine pump as a treatment option in chronic pain of nonmalignant origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

Intrathecal granuloma complicating chronic spinal infusion of morphine. Report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1525-1403.2002.02025.X

10.1046/J.1525-1403.2002.02025.X

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference